M. Hensel
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
- Genetics 11
- Chronic Lymphocytic Leukemia Research 11
-
- Lymphoma Diagnosis and Treatment 11
- Co-authors
- Anthony D. Ho (11 shared papers)Andreas Schneeweiß (5 shared papers)Gerlinde Egerer (4 shared papers)H. Goldschmidt (1 shared paper)Christiane Pott (2 shared papers)Michael Kneba (2 shared papers)Gerhard Ehninger (1 shared paper)T Held (1 shared paper)
In The Last Decade
M. Hensel
26 papers receiving 571 citations
Peers
Comparison fields: 5 of 58
- Genetics 242
- Hematology 226
- Pathology and Forensic Medicine 238
- Oncology 184
- Immunology 100
Countries citing papers authored by M. Hensel
This map shows the geographic impact of M. Hensel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hensel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hensel more than expected).
Fields of papers citing papers by M. Hensel
This network shows the impact of papers produced by M. Hensel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hensel. The network helps show where M. Hensel may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Hensel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 181 | |
| 2 | 2003 | 89 | |
| 3 | 2002 | 75 | |
| 4 | 2007 | 54 | |
| 5 | 2009 | 45 | |
| 6 | 2005 | 31 | |
| 7 | 2014 | 22 | |
| 8 | Efficacy of subcutaneous Alemtuzumab (Campath-1H) in genetic high-risk, fludarabine-refractory CLL: CLL2H study of the German CLL Study Group (GCLLSG) | 2005 | 17 |
| 9 | 2002 | 15 | |
| 10 | 2002 | 13 | |
| 11 | 2012 | 8 | |
| 12 | 2002 | 8 | |
| 13 | Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia. | 2002 | 7 |
| 14 | Phase II Study of Rituximab in Combination With Fludarabine in Patients With Chronic Lymphocytic Leukemia | 2002 | 7 |
| 15 | 2001 | 4 | |
| 16 | 2006 | 3 | |
| 17 | 2012 | 2 | |
| 18 | Disease Activity and Pretreatment, but Not Hypogammaglobulinemia, Are Risk Factors for Infectious Complications in Patients with Chronic Lymphocytic Leukemia | 2002 | 1 |
| 19 | 2008 | 1 | |
| 20 | 2024 | 1 |
About M. Hensel
M. Hensel is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Hematology and Public Health, Environmental and Occupational Health, having authored 26 papers that have together received 590 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Viral-associated cancers and disorders (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Genetics (242 citations), Hematology (226 citations), Pathology and Forensic Medicine (238 citations), Oncology (184 citations) and Immunology (100 citations). M. Hensel has collaborated with scholars based in Germany, Austria and Estonia. Frequent co-authors include Anthony D. Ho, Andreas Schneeweiß, Gerlinde Egerer, H. Goldschmidt, Christiane Pott, Michael Kneba, Gerhard Ehninger, T Held, W. Siegert and Joachim Kienast. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Leukemia, Annals of Hematology and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.